ACTIVATION OF NEUTRAL SPHINGOMYELINASE BY IL-1β REQUIRES THE TYPE 1 INTERLEUKIN 1 RECEPTOR
- 31 March 2000
- journal article
- Published by Elsevier BV in Cytokine
- Vol. 12 (3), 229-232
- https://doi.org/10.1006/cyto.1999.0547
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- INTERLEUKIN 1 (IL-1) TYPE I RECEPTORS MEDIATE ACTIVATION OF RAT HYPOTHALAMUS–PITUITARY–ADRENAL AXIS AND INTERLEUKIN 6 PRODUCTION AS SHOWN BY RECEPTOR TYPE SELECTIVE DELETION MUTANTS OF IL-1βCytokine, 1998
- Sphingomyelinase Activity Is Enhanced in Cerebral Cortex of Senescence-Accelerated Mouse-P/10 with Advancing AgeBiochemical and Biophysical Research Communications, 1997
- Ceramide: an endogenous regulator of apoptosis and growth suppresionImmunology Today, 1995
- Acid sphingomyelinase is not essential for the IL-1 and tumor necrosis factor receptor signaling pathway leading to NFkB activationInternational Immunology, 1994
- Deletion mutants of human interleukin 1β with significantly reduced agonist properties: Search for the agonist/antagonist switch in ligands to the interleukin 1 receptorsCytokine, 1994
- Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4Science, 1993
- Activation of the Sphingomyelin Signaling Pathway in Intact EL4 Cells and in a Cell-Free System By IL-1βScience, 1993
- Tumor Necrosis Factor-α Activates the Sphingomyelin Signal Transduction Pathway in a Cell-Free SystemScience, 1992
- Characterization of a neuronal interleukin-1 receptor and the corresponding mRNA in the mouse anterior pituitary cell line AtT-20Neuroscience Letters, 1991
- Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.JCI Insight, 1990